All Stories

  1. A systematic review on clinical adaptive radiotherapy for head and neck cancer

    Article • Acta Oncologica, August 2023, Taylor & Francis

    Professor Lena Specht

  2. The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis

    Article • Acta Oncologica, August 2023, Taylor & Francis

    Professor Lena Specht

  3. Personalised therapy in follicular lymphoma – is the dial turning?

    Article • Hematological Oncology, July 2023, Wiley

    Professor Lena Specht

  4. Career development: A balance of opportunities and choices

    Article • Hematological Oncology, June 2023, Wiley

    Professor Lena Specht

  5. Data from Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial

    Article • March 2023, American Association for Cancer Research (AACR)

    Professor Lena Specht

  6. Data from Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial

    Article • March 2023, American Association for Cancer Research (AACR)

    Professor Lena Specht

  7. Supplementary Data from Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial

    Article • March 2023, American Association for Cancer Research (AACR)

    Professor Lena Specht

  8. Supplementary Data from Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial

    Article • March 2023, American Association for Cancer Research (AACR)

    Professor Lena Specht

  9. Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial

    Article • Journal of Clinical Oncology, January 2023, American Society of Clinical Oncology (ASCO)

    Professor Lena Specht

  10. Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors

    Article • Acta Oncologica, September 2022, Taylor & Francis

    Professor Lena Specht

  11. Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma

    Article • Acta Oncologica, September 2022, Taylor & Francis

    Professor Lena Specht

  12. Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial

    Article • Clinical Cancer Research, April 2022, American Association for Cancer Research (AACR)

    Professor Lena Specht

  13. Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II)

    Article • Stem Cells Translational Medicine, April 2022, Oxford University Press (OUP)

    Professor Lena Specht

  14. Baseline FDG PET/CT in free breathing versus deep inspiration breath-hold for pediatric patients with mediastinal lymphoma

    Article • Acta Oncologica, September 2021, Taylor & Francis

    Professor Lena Specht

  15. Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma

    Article • European Journal of Radiology, June 2021, Elsevier

    Professor Lena Specht

  16. Hematological toxicity in patients with solid malignant tumors treated with radiation – Temporal analysis, dose response and impact on survival

    Article • Radiotherapy and Oncology, May 2021, Elsevier

    Professor Lena Specht

  17. Relapse localization in Danish pediatric patients with Hodgkin lymphoma

    Article • Acta Oncologica, March 2021, Taylor & Francis

    Professor Lena Specht

  18. Early-stage mantle cell lymphoma—a rare entity with special characteristics and needs for treatment

    Article • Annals of Hematology, September 2020, Springer Science + Business Media

    Professor Lena Specht

  19. Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome

    Article • Radiotherapy and Oncology, September 2020, Elsevier

    Professor Lena Specht

  20. Extranodal NK/T-cell lymphoma, nasal type, with extranasal presentation – a case report and a review of the literature

    Article • Acta Oncologica, July 2020, Taylor & Francis

    Professor Lena Specht

  21. ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

    Article • Blood, May 2020, American Society of Hematology

    Professor Lena Specht

  22. Biological optimization for mediastinal lymphoma radiotherapy – a preliminary study

    Article • Acta Oncologica, March 2020, Taylor & Francis

    Professor Lena Specht

  23. Cardiac Lymphoma, a Challenging Extranodal Lymphoma

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2020, Elsevier

    Professor Lena Specht

  24. Radiation dose-painting with protons vs. photons for head-and-neck cancer

    Article • Acta Oncologica, January 2020, Taylor & Francis

    Professor Lena Specht

  25. Incidence and survival of hypopharyngeal cancer: a Danish Nation-Wide Study from 1980 to 2014

    Article • Acta Oncologica, September 2019, Taylor & Francis

    Professor Lena Specht

  26. The Copenhagen Oral Cavity Squamous Cell Carcinoma database: protocol and report on establishing a comprehensive oral cavity cancer database

    Article • Clinical Epidemiology, August 2019, Taylor & Francis

    Professor Lena Specht, Elo Andersen

  27. The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2019, Elsevier

    Professor Lena Specht

  28. Incidence and survival of laryngeal cancer in Denmark: a nation-wide study from 1980 to 2014

    Article • Acta Oncologica, March 2019, Taylor & Francis

    Professor Lena Specht

  29. On the relation between improved loco-regional control and disease-free survival in head-and-neck cancer

    Article • Acta Oncologica, February 2019, Taylor & Francis

    Professor Lena Specht

  30. Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2018, Elsevier

    Professor Lena Specht

  31. Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma Radiation Oncology Group

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2018, Elsevier

    Professor Lena Specht

  32. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma

    Article • Oral Oncology, August 2018, Elsevier

    Professor Lena Specht

  33. Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma

    Article • Clinical Oncology, June 2018, Elsevier

    Professor Lena Specht

  34. DAHANCA 10 – Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group

    Article • Radiotherapy and Oncology, April 2018, Elsevier

    Professor Lena Specht

  35. Recommendations for the clinical management of the elderly patient with malignant lymphoma

    Article • Annals of Oncology, April 2018, Elsevier

    Professor Lena Specht

  36. TEDDI: radiotherapy delivery in deep inspiration for pediatric patients − a NOPHO feasibility study

    Article • Radiation Oncology, March 2018, Springer Science + Business Media

    Professor Lena Specht

  37. Incidence and survival in sinonasal carcinoma: a Danish population-based, nationwide study from 1980 to 2014

    Article • Acta Oncologica, March 2018, Taylor & Francis

    Professor Lena Specht

  38. Metal artefact reduction for accurate tumour delineation in radiotherapy

    Article • Radiotherapy and Oncology, March 2018, Elsevier

    Professor Lena Specht

  39. Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2018, Elsevier

    Professor Lena Specht

  40. Increasing incidence and survival of head and neck cancers in Denmark: a nation-wide study from 1980 to 2014

    Article • Acta Oncologica, February 2018, Taylor & Francis

    Professor Lena Specht

  41. Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2018, New England Journal of Medicine (NEJM/MMS)

    Professor Lena Specht

  42. PET/CT in Radiation Therapy Planning

    Article • Seminars in Nuclear Medicine, January 2018, Elsevier

    Professor Lena Specht

  43. A failure-type specific risk prediction tool for selection of head-and-neck cancer patients for experimental treatments

    Article • Oral Oncology, November 2017, Elsevier

    Professor Lena Specht

  44. Synchronous, bilateral tonsillar carcinomas: Patient characteristics and human papillomavirus genotypes

    Article • Oral Oncology, November 2017, Elsevier

    Professor Lena Specht

  45. Incidence and survival of oropharyngeal cancer in Denmark: a nation-wide, population-based study from 1980 to 2014

    Article • Acta Oncologica, October 2017, Taylor & Francis

    Professor Lena Specht

  46. Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold

    Article • Radiotherapy and Oncology, October 2017, Elsevier

    Professor Lena Specht

  47. Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)

    Article • Annals of Oncology, September 2017, Elsevier

    Professor Lena Specht

  48. Immunohistochemical and molecular imaging biomarker signature for the prediction of failure site after chemoradiation for head and neck squamous cell carcinoma

    Article • Acta Oncologica, August 2017, Taylor & Francis

    Professor Lena Specht

  49. Correlation between HPV status at T and N sites of oropharyngeal squamous cell carcinomas

    Article • Acta Oto-Laryngologica, July 2017, Taylor & Francis

    Professor Lena Specht

  50. Erratum: The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer

    Article • British Journal of Cancer, July 2017, Springer Science + Business Media

    Professor Lena Specht

  51. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

    Article • Journal of Clinical Oncology, June 2017, American Society of Clinical Oncology (ASCO)

    Professor Lena Specht

  52. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma

    Article • Cochrane Database of Systematic Reviews, April 2017, Wiley

    Professor Lena Specht

  53. Increasing incidence and survival in oral cancer: a nationwide Danish study from 1980 to 2014

    Article • Acta Oncologica, April 2017, Taylor & Francis

    Professor Lena Specht

  54. Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study

    Article • International Journal of Cancer, March 2017, Wiley

    Professor Lena Specht

  55. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial

    Article • Trials, March 2017, Springer Science + Business Media

    Professor Lena Specht

  56. Construction of a pathological risk model of occult lymph node metastases for prognostication by semi-automated image analysis of tumor budding in early-stage oral squamous cell carcinoma

    Article • Oncotarget, February 2017, Impact Journals, LLC

    Professor Lena Specht

  57. Ultrasonic mirror image from ruthenium plaque facilitates calculation of uveal melanoma treatment dose

    Article • British Journal of Ophthalmology, February 2017, BMJ

    Professor Lena Specht

  58. Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group

    Article • Acta Oncologica, January 2017, Taylor & Francis

    Professor Lena Specht

  59. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014

    Article • European Journal of Cancer, January 2017, Elsevier

    Professor Lena Specht

  60. Deep inspiration breath-hold radiotherapy for lung cancer: impact on image quality and registration uncertainty in cone beam CT image guidance

    Article • British Journal of Radiology, December 2016, British Institute of Radiology

    Professor Lena Specht

  61. Liquid fiducial marker performance during radiotherapy of locally advanced non small cell lung cancer

    Article • Radiotherapy and Oncology, October 2016, Elsevier

    Professor Lena Specht

  62. Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients

    Article • Oncotarget, September 2016, Impact Journals, LLC

    Professor Lena Specht

  63. Ionizing Radiation and High-Fat Diet: Risk for Insulin Resistance and Epigenetic Changes

    Article • Diabetes, September 2016, American Diabetes Association

    Professor Lena Specht

  64. Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma

    Article • Journal of Nuclear Medicine, September 2016, Society of Nuclear Medicine

    Professor Lena Specht

  65. In Reply to Gunn and Garden

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2016, Elsevier

    Professor Lena Specht

  66. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study

    Article • International Journal of Cancer, August 2016, Wiley

    Professor Lena Specht

  67. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer

    Article • Radiotherapy and Oncology, July 2016, Elsevier

    Professor Lena Specht

  68. Chemotherapeutic treatment is associated with Notch1 induction in cutaneous T-cell lymphoma

    Article • Leukemia & Lymphoma, May 2016, Taylor & Francis

    Professor Lena Specht

  69. Editorial: Diffuse large B-cell lymphoma: survival of the fittest?

    Article • European Journal Of Haematology, March 2016, Wiley

    Professor Lena Specht

  70. Deep inspiration breath-hold volumetric modulated arc radiotherapy decreases dose to mediastinal structures in locally advanced lung cancer

    Article • Acta Oncologica, March 2016, Taylor & Francis

    Professor Lena Specht

  71. Elective Nodal Irradiation and Patterns of Failure in Head and Neck Cancer After Primary Radiation Therapy

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2016, Elsevier

    Professor Lena Specht

  72. Geometric uncertainties in voluntary deep inspiration breath hold radiotherapy for locally advanced lung cancer

    Article • Radiotherapy and Oncology, March 2016, Elsevier

    Professor Lena Specht

  73. Does Radiation Have a Role in Advanced Stage Hodgkin’s or Non-Hodgkin Lymphoma?

    Article • Current Treatment Options in Oncology, January 2016, Springer Science + Business Media

    Professor Lena Specht

  74. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials

    Article • The Lancet Haematology, November 2015, Elsevier

    Professor Lena Specht

  75. Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting

    Article • Acta Oncologica, September 2015, Taylor & Francis

    Professor Lena Specht

  76. Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: A retrospective single-center study

    Article • Head & Neck, September 2015, Wiley

    Professor Lena Specht

  77. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Article • Annals of Oncology, September 2015, Elsevier

    Professor Lena Specht

  78. Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma

    Article • Acta Oncologica, August 2015, Taylor & Francis

    Professor Lena Specht

  79. The concept and evolution of involved site radiation therapy for lymphoma

    Article • International Journal of Clinical Oncology, July 2015, Springer Science + Business Media

    Professor Lena Specht

  80. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma

    Article • The Journal of Pathology, June 2015, Wiley

    Professor Lena Specht

  81. Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients

    Article • British Journal of Cancer, June 2015, Springer Science + Business Media

    Professor Lena Specht

  82. Minimizing Late Effects for Patients With Mediastinal Hodgkin Lymphoma: Deep Inspiration Breath-Hold, IMRT, or Both?

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2015, Elsevier

    Professor Lena Specht

  83. Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2015, Elsevier

    Professor Lena Specht

  84. Low-Dose (10-Gy) Total Skin Electron Beam Therapy for Cutaneous T-Cell Lymphoma: An Open Clinical Study and Pooled Data Analysis

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2015, Elsevier

    Professor Lena Specht

  85. Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2015, Elsevier

    Professor Lena Specht

  86. Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Lymphoma Radiation Oncology Group

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2015, Elsevier

    Professor Lena Specht

  87. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

    Article • The Lancet Oncology, May 2015, Elsevier

    Naomi Kiyota, Professor Orlando Guntinas-Lichius, Professor Lena Specht

  88. Reproducibility of18F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR

    Article • British Journal of Radiology, April 2015, British Institute of Radiology

    Professor Lena Specht

  89. A new method to estimate doses to the normal tissues after past extended and involved field radiotherapy for Hodgkin lymphoma

    Article • Radiotherapy and Oncology, February 2015, Elsevier

    Professor Lena Specht

  90. Prognostic Factors

    Article • December 2014, Springer Science + Business Media

    Professor Lena Specht

  91. H odgkin's Disease

    Article • December 2014, Wiley

    Professor Lena Specht

  92. A Decade of Comparative Dose Planning Studies for Early-Stage Hodgkin Lymphoma: What Can We Learn?

    Article • International Journal of Radiation Oncology*Biology*Physics, December 2014, Elsevier

    Professor Lena Specht

  93. Human Papillomavirus in Head and Neck Squamous Cell Carcinoma of Unknown Primary Is a Common Event and a Strong Predictor of Survival

    Article • PLoS ONE, November 2014, PLOS

    Professor Lena Specht

  94. The EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Treatment outcome in a single institution cohort

    Article • Acta Oncologica, October 2014, Taylor & Francis

    Professor Lena Specht

  95. Comment on: “Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study)”

    Article • The Oncologist, October 2014, Oxford University Press (OUP)

    Professor Lena Specht

  96. A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: The largest registry-based study to date

    Article • International Journal of Cancer, October 2014, Wiley

    Professor Lena Specht

  97. In Vivo Treatment Sensitivity Testing With Positron Emission Tomography/Computed Tomography After One Cycle of Chemotherapy for Hodgkin Lymphoma

    Article • Journal of Clinical Oncology, September 2014, American Society of Clinical Oncology (ASCO)

    Professor Lena Specht

  98. Follicular lymphoma of the ocular adnexal region: A nation-based study

    Article • Acta Ophthalmologica, August 2014, Wiley

    Professor Lena Specht

  99. Geometric distortions of diffusion weighted imaging of the head/neck in combined PET/MR: optimization of image acquisition and post-processing correction for oncology applications

    Article • EJNMMI Physics, July 2014, Springer Science + Business Media

    Professor Andreas Kjaer, Professor Lena Specht

  100. Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma

    Article • Head & Neck, July 2014, Wiley

    Professor Lena Specht

  101. Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: Benefit of deep inspiration breath-hold

    Article • Acta Oncologica, July 2014, Taylor & Francis

    Professor Lena Specht

  102. Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2014, Elsevier

    Professor Lena Specht

  103. Prescribing and evaluating target dose in dose-painting treatment plans

    Article • Acta Oncologica, June 2014, Taylor & Francis

    Professor Lena Specht

  104. Cardiovascular disease after cancer therapy

    Article • European Journal of Cancer Supplements, June 2014, Elsevier

    Professor Lena Specht

  105. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake

    Article • Radiotherapy and Oncology, June 2014, Elsevier

    Professor Lena Specht

  106. Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2014, Elsevier

    Professor Lena Specht

  107. MiR-21 Expression in the Tumor Stroma of Oral Squamous Cell Carcinoma: An Independent Biomarker of Disease Free Survival

    Article • PLoS ONE, April 2014, PLOS

    Professor Lena Specht

  108. Radiotherapy for indolent lymphomas: how much is enough?

    Article • The Lancet Oncology, April 2014, Elsevier

    Professor Lena Specht

  109. Mesenchymal stem cell therapy for salivary gland dysfunction and xerostomia: a systematic review of preclinical studies

    Article • Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, March 2014, Elsevier

    Professor Lena Specht

  110. Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy

    Article • Radiotherapy and Oncology, March 2014, Elsevier

    Professor Lena Specht

  111. Edited by AnasYounes and BertrandCoiffier (Eds.) Lymphoma. Diagnosis and Treatment. Humana Press, New York, 2013, 411 pages.

    Article • European Journal Of Haematology, February 2014, Wiley

    Professor Lena Specht

  112. Interactive Decision-Support Tool for Risk-Based Radiation Therapy Plan Comparison for Hodgkin Lymphoma

    Article • International Journal of Radiation Oncology*Biology*Physics, February 2014, Elsevier

    Professor Lena Specht

  113. Heart, Coronary Arteries, Aorta and Great Vessels, Arteries and Veins, Microcirculation

    Article • December 2013, Springer Science + Business Media

    Professor Lena Specht

  114. Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: Minimizing the life years lost attributable to failure to control the disease and late complication risk

    Article • Acta Oncologica, November 2013, Taylor & Francis

    Professor Lena Specht

  115. The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma

    Article • Pediatric Blood & Cancer, November 2013, Wiley

    Professor Lena Specht

  116. Human papillomavirus and oropharyngeal cancer in Greenland in 1994–2010

    Article • International Journal of Circumpolar Health, November 2013, Co-Action Publishing

    Professor Lena Specht

  117. Three-year follow-up of sentinel node-negative patients with early oral cavity squamous cell carcinoma

    Article • Head & Neck, October 2013, Wiley

    Professor Lena Specht

  118. Lena Specht

    Article • Journal of Geriatric Oncology, October 2013, Elsevier

    Professor Lena Specht

  119. Doses to Carotid Arteries After Modern Radiation Therapy for Hodgkin Lymphoma: Is Stroke Still a Late Effect of Treatment?

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2013, Elsevier

    Professor Lena Specht

  120. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Article • Annals of Oncology, October 2013, Elsevier

    Professor Lena Specht

  121. The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma

    Article • Acta Oncologica, September 2013, Taylor & Francis

    Professor Lena Specht

  122. Deep inspiration breath hold radiotherapy for locally advanced lung cancer: Comparison of different treatment techniques on target coverage, lung dose and treatment delivery time

    Article • Acta Oncologica, September 2013, Taylor & Francis

    Professor Lena Specht

  123. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer

    Article • Acta Oncologica, September 2013, Taylor & Francis

    Professor Lena Specht

  124. Stability of percutaneously implanted markers for lung stereotactic radiotherapy

    Article • Journal of Applied Clinical Medical Physics, September 2013, Wiley

    Professor Lena Specht

  125. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma

    Article • Annals of Oncology, August 2013, Elsevier

    Professor Lena Specht

  126. Ten-year retrospective study of head and neck carcinoma in situ: incidence, treatment, and clinical outcome

    Article • Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, August 2013, Elsevier

    Professor Lena Specht

  127. T-Cell Lymphomas FrancineFoss (ed.) Humana Press, New York, 2013, 340 pages.

    Article • European Journal Of Haematology, July 2013, Wiley

    Professor Lena Specht

  128. Three-dimensional MRI-linac intra-fraction guidance using multiple orthogonal cine-MRI planes

    Article • Physics in Medicine and Biology, June 2013, Institute of Physics Publishing

    Professor Lena Specht

  129. OP182

    Article • Oral Oncology, May 2013, Elsevier

    Professor Lena Specht

  130. Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study

    Article • Annals of Oncology, May 2013, Elsevier

    Prof. Emanuele Zucca, Professor Lena Specht

  131. Involved Node Radiation Therapy: An Effective Alternative in Early-Stage Hodgkin Lymphoma

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2013, Elsevier

    Professor Lena Specht

  132. Interim positron emission tomography in early stage Hodgkin lymphoma: is there evidence for its prognostic and predictive value in patients treated with standard combined modality treatment?

    Article • Leukemia & Lymphoma, February 2013, Taylor & Francis

    Professor Lena Specht

  133. Percutaneously implanted markers in peripheral lung tumours: Report of complications

    Article • Acta Oncologica, February 2013, Taylor & Francis

    Professor Lena Specht

  134. Evaluation of methods for selecting the midventilation bin in 4DCT scans of lung cancer patients

    Article • Acta Oncologica, January 2013, Taylor & Francis

    Professor Lena Specht

  135. Failure-probability driven dose painting

    Article • Medical Physics, January 2013, American Association of Physicists in Medicine (AAPM)

    Professor Lena Specht

  136. Differences in Radiotherapy Delivery and Outcome Due to Contouring Variation

    Article • January 2013, Springer Science + Business Media

    Professor Lena Specht

  137. Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma

    Article • Journal of Clinical Oncology, December 2012, American Society of Clinical Oncology (ASCO)

    Professor Lena Specht

  138. Interobserver delineation variation in lung tumour stereotactic body radiotherapy

    Article • British Journal of Radiology, September 2012, British Institute of Radiology

    Professor Lena Specht

  139. Risk of Developing Cardiovascular Disease After Involved Node Radiotherapy Versus Mantle Field for Hodgkin Lymphoma

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2012, Elsevier

    Professor Lena Specht

  140. Radiotherapy Studies and Extra-nodal Non-Hodgkin Lymphomas, Progress and Challenges

    Article • Clinical Oncology, June 2012, Elsevier

    Professor Lena Specht

  141. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma

    Article • Strahlentherapie und Onkologie, May 2012, Springer Science + Business Media

    Professor Lena Specht

  142. Life years lost-comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale

    Article • Cancer, April 2012, Wiley

    Professor Lena Specht

  143. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer

    Article • British Journal of Cancer, April 2012, Springer Science + Business Media

    Professor Lena Specht

  144. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer

    Article • Radiotherapy and Oncology, April 2012, Elsevier

    Professor Lena Specht

  145. Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study

    Article • British Journal of Dermatology, January 2012, Oxford University Press (OUP)

    Professor Lena Specht

  146. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs

    Article • Haematologica, December 2011, Ferrata Storti Foundation (Haematologica)

    Professor Lena Specht

  147. Artifacts in Conventional Computed Tomography (CT) and Free Breathing Four-Dimensional CT Induce Uncertainty in Gross Tumor Volume Determination

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2011, Elsevier

    Professor Lena Specht

  148. Evaluation of dose to cardiac structures during breast irradiation

    Article • British Journal of Radiology, August 2011, British Institute of Radiology

    Professor Lena Specht

  149. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – Results from the randomized DAHANCA 5 and 7 trials

    Article • Acta Oncologica, July 2011, Taylor & Francis

    Professor Lena Specht

  150. Total skin electron beam therapy for cutaneous T-cell lymphoma: A nationwide cohort study from Denmark

    Article • Acta Oncologica, July 2011, Taylor & Francis

    Professor Lena Specht

  151. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial

    Article • Radiotherapy and Oncology, July 2011, Elsevier

    Professor Lena Specht

  152. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study

    Article • Oral Oncology, June 2011, Elsevier

    Professor Lena Specht

  153. Risk factors for radiation-induced hypothyroidism

    Article • Cancer, May 2011, Wiley

    Professor Lena Specht

  154. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

    Article • February 2011, Wiley

    Professor Lena Specht

  155. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study

    Article • British Journal of Cancer, February 2011, Springer Science + Business Media

    Professor Lena Specht

  156. The prevalence of occult metastases in nonsentinel lymph nodes after step-serial sectioning and immunohistochemistry in cN0 oral squamous cell carcinoma

    Article • The Laryngoscope, January 2011, Wiley

    Professor Lena Specht

  157. Radiotherapy for Hodgkin Lymphoma

    Article • January 2011, Springer Science + Business Media

    Professor Lena Specht

  158. Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes

    Article • Acta Oncologica, September 2010, Taylor & Francis

    Professor Lena Specht

  159. Survival of head and neck cancer in Greenland

    Article • International Journal of Circumpolar Health, September 2010, Co-Action Publishing

    Professor Lena Specht

  160. Proton Therapy for Hodgkin Lymphoma

    Article • August 2010, Springer Science + Business Media

    Professor Lena Specht

  161. Future Prospects for Radiotherapy for Hodgkin Lymphoma

    Article • August 2010, Springer Science + Business Media

    Professor Lena Specht

  162. History of Radiotherapy of Hodgkin’s Disease (Now Hodgkin Lymphoma)

    Article • August 2010, Springer Science + Business Media

    Professor Lena Specht

  163. Evaluation of Response After Radiotherapy for Hodgkin Lymphoma

    Article • August 2010, Springer Science + Business Media

    Professor Lena Specht

  164. Traditional and Modern Techniques for Radiation Treatment Planning

    Article • August 2010, Springer Science + Business Media

    Professor Lena Specht

  165. Background and Rationale for Radiotherapy in Early-Stage Hodgkin Lymphoma

    Article • August 2010, Springer Science + Business Media

    Professor Lena Specht

  166. Target Definitions for Hodgkin Lymphoma: The Involved Node Radiation Field Concept

    Article • August 2010, Springer Science + Business Media

    Professor Lena Specht

  167. Prognostic Factors

    Article • August 2010, Springer Science + Business Media

    Professor Lena Specht

  168. Staging systems and staging investigations at presentation

    Article • July 2010, Taylor & Francis

    Professor Lena Specht

  169. Deviations in delineated GTV caused by artefacts in 4DCT

    Article • Radiotherapy and Oncology, July 2010, Elsevier

    Professor Lena Specht

  170. Chemotherapy alone vs. radiotherapy alone vs. chemotherapy plus radiotherapy in the primary treatment of localised non-Hodgkin's lymphoma

    Article • February 2010, Wiley

    Professor Lena Specht

  171. Erosive potential of saliva stimulating tablets with and without fluoride in irradiated head and neck cancer patients

    Article • Radiotherapy and Oncology, December 2009, Elsevier

    Professor Lena Specht

  172. Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review

    Article • Haematologica, November 2009, Ferrata Storti Foundation (Haematologica)

    Professor Lena Specht

  173. Improved prognosis for localized malignant lymphomas of the head and neck

    Article • Acta Oto-Laryngologica, November 2009, Taylor & Francis

    Professor Lena Specht

  174. The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: Implications for tumour coverage

    Article • Radiotherapy and Oncology, June 2009, Elsevier

    Professor Lena Specht

  175. Hodgkin's disease and age*

    Article • European Journal Of Haematology, April 2009, Wiley

    Professor Lena Specht

  176. Hodgkin's disease: Recent concepts in classification and treatment

    Article • European Journal Of Haematology, April 2009, Wiley

    Professor Lena Specht

  177. Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease

    Article • Scandinavian Journal of Haematology, April 2009, Wiley

    Professor Lena Specht

  178. Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden

    Article • European Journal Of Haematology, April 2009, Wiley

    Professor Lena Specht

  179. Prognostic factors in Hodgkin's disease stage IV

    Article • European Journal Of Haematology, April 2009, Wiley

    Professor Lena Specht

  180. Prognostic significance of tumour burden in Hodgkin's disease PS I and II

    Article • Scandinavian Journal of Haematology, April 2009, Wiley

    Professor Lena Specht

  181. Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease

    Article • Scandinavian Journal of Haematology, April 2009, Wiley

    Professor Lena Specht

  182. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease

    Article • European Journal Of Haematology, April 2009, Wiley

    Professor Lena Specht

  183. Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II

    Article • Scandinavian Journal of Haematology, April 2009, Wiley

    Professor Lena Specht

  184. The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines

    Article • Radiotherapy and Oncology, August 2008, Elsevier

    Professor Lena Specht

  185. A Prospective, Open-Label Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2008, Elsevier

    Professor Lena Specht

  186. PET/CT in the management of haematological malignancies

    Article • European Journal Of Haematology, May 2008, Wiley

    Professor Lena Specht

  187. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin Lymphoma

    Article • April 2008, Wiley

    Professor Lena Specht

  188. Need for Intensive Histopathologic Analysis to Determine Lymph Node Metastases When Using Sentinel Node Biopsy in Oral Cancer

    Article • The Laryngoscope, March 2008, Wiley

    Professor Lena Specht

  189. The nimorazole regimen in patients with head and neck cancer can increase the effect of vitamin K antagonists

    Article • Acta Oncologica, January 2008, Taylor & Francis

    Professor Lena Specht

  190. The role of image guidance in respiratory gated radiotherapy

    Article • Acta Oncologica, January 2008, Taylor & Francis

    Professor Lena Specht

  191. Papillary microcarcinoma of the thyroid gland: Is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?

    Article • Acta Oncologica, January 2008, Taylor & Francis

    Professor Lena Specht

  192. Interfractional changes in tumour volume and position during entire radiotherapy courses for lung cancer with respiratory gating and image guidance

    Article • Acta Oncologica, January 2008, Taylor & Francis

    Professor Lena Specht

  193. Can audio coached 4D CT emulate free breathing during the treatment course?

    Article • Acta Oncologica, January 2008, Taylor & Francis

    Professor Lena Specht

  194. FDG-PET scan and treatment planning for early stage Hodgkin lymphoma

    Article • Radiotherapy and Oncology, November 2007, Elsevier

    Professor Lena Specht

  195. Do We Need an Early Unfavorable (Intermediate) Stage of Hodgkin's Lymphoma?

    Article • Hematology/Oncology Clinics of North America, October 2007, Elsevier

    Professor Lena Specht

  196. Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck

    Article • Radiotherapy and Oncology, October 2007, Elsevier

    Professor Lena Specht

  197. Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

    Article • Journal of Clinical Oncology, August 2007, American Society of Clinical Oncology (ASCO)

    Professor Lena Specht

  198. 2-[18F]Fluoro-2-Deoxyglucose Positron-Emission Tomography in Staging, Response Evaluation, and Treatment Planning of Lymphomas

    Article • Seminars in Radiation Oncology, July 2007, Elsevier

    Professor Lena Specht

  199. Intra- and interfraction breathing variations during curative radiotherapy for lung cancer

    Article • Radiotherapy and Oncology, July 2007, Elsevier

    Professor Lena Specht

  200. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma

    Article • European Journal Of Haematology, March 2007, Wiley

    Professor Lena Specht

  201. PET/CT in head and neck cancer

    Article • European Journal of Pediatrics, February 2007, Springer Science + Business Media

    Professor Lena Specht

  202. Revised Response Criteria for Malignant Lymphoma

    Article • Journal of Clinical Oncology, February 2007, American Society of Clinical Oncology (ASCO)

    Prof. Emanuele Zucca, Professor Lena Specht

  203. Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy

    Article • Acta Oncologica, January 2007, Taylor & Francis

    Professor Lena Specht

  204. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials

    Article • Annals of Oncology, December 2006, Elsevier

    Professor Lena Specht

  205. Cardiac and pulmonary complication probabilities for breast cancer patients after routine end-inspiration gated radiotherapy

    Article • Radiotherapy and Oncology, August 2006, Elsevier

    Professor Lena Specht

  206. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2006, Elsevier

    Professor Lena Specht

  207. Hodgkin Lymphoma

    Article • July 2006, Wiley

    Professor Lena Specht

  208. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines

    Article • Radiotherapy and Oncology, June 2006, Elsevier

    Professor Lena Specht

  209. Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake

    Article • Hematological Oncology, January 2006, Wiley

    Professor Lena Specht

  210. The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer

    Article • Acta Oto-Laryngologica, January 2006, Taylor & Francis

    Professor Lena Specht

  211. The Danish national guidelines for treatment of oral squamous cell carcinoma

    Article • Acta Oncologica, January 2006, Taylor & Francis

    Professor Lena Specht

  212. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma

    Article • Blood, January 2006, American Society of Hematology

    Professor Lena Specht

  213. Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk

    Article • Cochrane Database of Systematic Reviews, October 2005, Wiley

    Professor Lena Specht

  214. Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique

    Article • Radiotherapy and Oncology, September 2005, Elsevier

    Professor Lena Specht

  215. Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy

    Article • European Journal Of Haematology, June 2005, Wiley

    Professor Lena Specht

  216. Nimorazole may increase the effect of phenprocoumon

    Article • Radiotherapy and Oncology, March 2005, Elsevier

    Professor Lena Specht

  217. FDG-PET in the clinical management of Hodgkin lymphoma

    Article • Critical Reviews in Oncology/Hematology, October 2004, Elsevier

    Professor Lena Specht

  218. Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy

    Article • Cancer Treatment Reviews, August 2004, Elsevier

    Professor Lena Specht

  219. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold

    Article • Radiotherapy and Oncology, July 2004, Elsevier

    Professor Lena Specht

  220. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

    Article • The Lancet, September 2003, Elsevier

    Professor Lena Specht

  221. In response to Dr. Remouchamps

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2003, Elsevier

    Professor Lena Specht

  222. Chemotherapy alone vs. radiotherapy alone vs. chemotherapy plus radiotherapy in the primary treatment of localised non-Hodgkin's lymphoma

    Article • January 2003, Wiley

    Professor Lena Specht

  223. Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin’s lymphoma and chronic lymphocytic leukemia

    Article • International Journal of Radiation Oncology*Biology*Physics, December 2002, Elsevier

    Professor Lena Specht

  224. Oral complications in the head and neck radiation patient

    Article • Supportive Care in Cancer, January 2002, Springer Science + Business Media

    Professor Lena Specht

  225. Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Seminoma Stage I Followed with Surveillance

    Article • Acta Oncologica, January 2002, Taylor & Francis

    Professor Lena Specht

  226. Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation

    Article • Journal of Oral and Maxillofacial Surgery, October 2000, Elsevier

    Professor Lena Specht

  227. Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

    Article • Annals of Oncology, July 2000, Elsevier

    Professor Lena Specht

  228. PROGNOSTIC FACTORS FOR RELAPSE IN STAGE I SEMINOMA MANAGED BY SURVEILLANCE

    Article • The Journal of Urology, April 1999, Elsevier

    Professor Lena Specht

  229. A Prognostic Score for Advanced Hodgkin's Disease

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 1998, New England Journal of Medicine (NEJM/MMS)

    Professor Lena Specht

  230. Transitory blindness after retrobulbar irradiation of Graves' ophthalmopathy

    Article • The Lancet, March 1998, Elsevier

    Professor Lena Specht

  231. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

    Article • Radiotherapy and Oncology, February 1998, Elsevier

    Professor Lena Specht

  232. Survival analysis of patients with clinical stages I or II Hodgkin's disease who have relapsed after initial treatment with radiotherapy alone

    Article • European Journal of Cancer, May 1997, Elsevier

    Professor Lena Specht

  233. Prognostic factors in Hodgkin's disease

    Article • Seminars in Radiation Oncology, July 1996, Elsevier

    Professor Lena Specht

  234. Salvage of relapse of patients with Hodgkin's disease in clinical stages I or II who were staged with laparotomy and initially treated with radiotherapy alone. A report from the International Database on Hodgkin's disease

    Article • International Journal of Radiation Oncology*Biology*Physics, November 1994, Elsevier

    Professor Lena Specht

  235. Surveillance following orchidectomy for stage I seminoma of the testis

    Article • European Journal of Cancer, January 1993, Elsevier

    Professor Lena Specht

  236. The integration of radiotherapy into the primary treatment of non-Hodgkin's lymphoma

    Article • Critical Reviews in Oncology/Hematology, May 1992, Elsevier

    Professor Lena Specht

  237. Tumour burden as the main indicator of prognosis in Hodgkin's disease

    Article • European Journal of Cancer, January 1992, Elsevier

    Professor Lena Specht

  238. Prognostic factors in Hodgkin's disease

    Article • Cancer Treatment Reviews, March 1991, Elsevier

    Professor Lena Specht

  239. Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease

    Article • Cancer, June 1990, Wiley

    Professor Lena Specht

  240. Tumor burden as the most important prognostic factor in early stage Hodgkin's disease.Relations to other prognostic factors and implications for choice of treatment

    Article • Cancer, April 1988, Wiley

    Professor Lena Specht

  241. RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE

    Article • The Lancet, July 1987, Elsevier

    Professor Lena Specht

  242. Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy

    Article • British Journal of Cancer, May 1987, Springer Science + Business Media

    Professor Lena Specht